Prestigious competition for budding scientists takes a biotech vibe
For once, the biopharma industry has generated some happy news: the Society for Science and the Public (SSP), managers of the Science Talent Search for American high school students, has selected Regeneron Pharma as the sponsor for the next 10 years. Regeneron replaces Intel, which was the sponsor since 1998; back then, it had replaced the original sponsor, Westinghouse. The Westinghouse Science Talent Search began in 1942; going forward it will be known as the Regeneron Science Talent Search. Regeneron is committing $100 million over the next 10 years; Intel is supporting another SPP competition, the International Science and Engineering Fair, held for the first time this year.
George Yancopoulos as a Westinghouse STS finalist; and today.
Regeneron’s sponsorship is an all-around feel-good story: George Yancopoulos, Regeneron chief science officer and a first-generation American immigrant, was an STS finalist in 1976 (and Leonard Schleifer, Regeneron founder and CEO, was another STS participant); both express a strong desire to “give back” to science education. Regeneron itself is moving up in the biopharma world; its Praluent PCSK9 cholesterol treatment, co-marketed with Sanofi, is among the successes that have made both Schleifer and Yancopoulos billionaires.
There’s a neat history-of-science aspect to the transition. From its early days with Westinghouse, an electrical power giant in the 20th century, to Intel, the premier microprocessor manufacturer, to, now an up-and-coming biotech player. STS, now in its 75th year, has dozens of Nobel Prize, Fields Medal and other award-winners in its alumni ranks. The competition for the 2017 awards begins next month and will be announced next March.
Save
Save
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.